HTA143 Are HTA Agencies Willing to Accept Single-Arm Trials as the Main Source of Clinical Evidence for the Assessment of Pediatric Orphan Drugs When Faced With Extenuating Ethical and Medical Circumstances?

Dec 1, 2022, 00:00 AM
10.1016/j.jval.2022.09.1601
https://www.valueinhealthjournal.com/article/S1098-3015(22)03806-2/fulltext
Section Title :
Section Order : 11154
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03806-2&doi=10.1016/j.jval.2022.09.1601
HEOR Topics :
Tags :
Regions :